US 9,808,510 B2
Method for delivering gonadotropin releasing hormone into a lumen of the intestinal tract
Mir Imran, Los Altos Hills, CA (US)
Assigned to Rani Therapeutics, LLC, San Jose, CA (US)
Filed by Rani Therapeutics, LLC, San Jose, CA (US)
Filed on Feb. 19, 2016, as Appl. No. 15/48,085.
Application 15/048,085 is a continuation of application No. 13/538,841, filed on Jun. 29, 2012, granted, now 9,283,179.
Claims priority of provisional application 61/571,652, filed on Jun. 30, 2011.
Claims priority of provisional application 61/571,641, filed on Jun. 29, 2011.
Prior Publication US 2016/0166650 A1, Jun. 16, 2016
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 38/22 (2006.01); A61K 9/00 (2006.01); A61M 25/10 (2013.01); A61M 5/00 (2006.01); A61K 38/09 (2006.01); A61K 9/48 (2006.01); A61M 37/00 (2006.01); A61M 31/00 (2006.01)
CPC A61K 38/22 (2013.01) [A61K 9/0009 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 9/0065 (2013.01); A61K 9/4891 (2013.01); A61K 38/09 (2013.01); A61M 5/00 (2013.01); A61M 25/10 (2013.01); A61M 37/0015 (2013.01); A61M 31/002 (2013.01); A61M 2037/0023 (2013.01); A61M 2037/0061 (2013.01); A61M 2210/1042 (2013.01)] 26 Claims
 
1. A method for delivering a gonadotropin releasing hormone (GnRH) or a GnRH analogue dosage to a patient in need thereof, the method comprising:
orally delivery in a capsule a solid GnRH or GnRH analogue dosage shaped as a tissue penetrating member; and
penetrating the tissue penetrating member into an intestinal wall from the capsule after oral ingestion of the capsule, wherein the GnRH or GnRH analogue is released into the blood stream from the solid dosage GnRH or GnRH analogue in the intestinal wall.